Brewster Drug, Inc.; Decision and Order

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Justice Drug Enforcement Administration On October 26, 2017, the DEA Acting Administrator issued an Order to Show Cause and Immediate Suspension of Registration (hereinafter collectively, OSC), to Brewster Drug, Inc. (hereinafter, Registrant), of Brewster, Washington. The OSC informed Registrant of the immediate suspension of its DEA Certificate of Registration AB6785161 and proposed its revocation, the denial of any pending application for renewal or modification of such registration, and the denial of any applications for additional DEA registrations, on the ground that its “continued registration is inconsistent with the public interest.” OSC, at 1 (citing 21 U.S.C. 824(a)(4) and 823(f) ). The OSC alleged that Registrant is a corporate entity in the state of Washington. Id. at 2. It further alleged that “Brian Johnson and Nikki Johnson are the [Registrant's] `Governing Persons'—as defined in the Revised Code of Washington (RCW) 23.95.105(12),” and that “Brian Johnson is listed as the Pharmacy's Registered Agent by the Washington State Corporation commission.” Id. It further alleged that Brian Johnson is Registrant's Pharmacist-in-Charge (hereinafter, PIC). Id. The OSC alleged that “DEA's investigation [of Registrant] has revealed separate types of misconduct, which, taken together, pose an imminent danger to public health or safety.” Id. at 2. Specifically, DEA conducted inspections of Registrant on August…